The Indefinite Delivery Contract (IDC) No. 75Q80120D00017 was awarded by the Agency for Healthcare Research and Quality (AHRQ), a civilian federal agency, to Medstar Health Research Institute Inc. (a non-profit organization) as part of the Accelerating Change and Transformation in Organizations and Networks IV (ACTION IV) IDIQ contract vehicle. This multiple-award IDC, with a ceiling value of $5 million and a period of performance through May 2025, allows AHRQ to issue task orders for a variety of clinical and research services from Medstar Health Research Institute, including cardiovascular magnetic resonance imaging (MRI) consumables, on-call cardiothoracic physician specialty care, and other areas of expertise leveraged from its parent organization Medstar Health, Inc.
The original solicitation for the broader ACTION IV IDIQ anticipated procuring a range of services to support organizational change and transformation initiatives across the healthcare sector. While no set-asides were used, Medstar Health Research Institute has a history of collaborating with government agencies like the NIH, FDA, DoD, and VA on past contracts and grants, often as a prime or subcontractor, bringing its capabilities in areas such as clinical trials, data analytics, and biorepository maintenance. The IDC award to Medstar aligns with AHRQ's mission to generate evidence and promote improvements in the quality, safety, accessibility, and value of healthcare.
Generated 6/21/24, 9:14 AM